| Literature DB >> 29370108 |
Yalin Zhou1,2,3,4, Xiaoyong Chen5,6,7,8, Ruokun Yi9,10,11,12, Guijie Li13,14,15,16, Peng Sun17,18,19,20, Yu Qian21,22,23,24, Xin Zhao25,26,27,28.
Abstract
Polysaccharides are closely associated with immune regulation, but there are different polysaccharide effects from different sources. In this study, the aim was to investigate the effect of tremella polysaccharides (TP) in cyclophosphamide-induced immunodeficient mice. We observed the thymus and spleen index, liver and spleen pathological changes, and the levels of IL-2, IL-12, INF-γ, TGF-β and Ig G in serum, and we also noted the mRNA expression of IL-1β, IL-4, IL-12 and TGF-β in liver and spleen. Besides, we also measured the best effects of different doses of TP (Low-TP was 20 mg/kg·BW, Middle-TP was 40 mg/kg·BW, and High-TP was 80 mg/kg·BW) on cyclophosphamide-induced immunosuppressed mice. The results were remarkable, and suggested that TP had a significant effect for enhancing immunity in cyclophosphamide-induced immunosuppression, and the immune enhancement of High-TP had the best results in TP-treated mice. It could significantly increase the thymus and spleen index, alleviate pathological features of immunosuppression such as the arrangement of liver sinusoid and hepatic plates was disordered, massive inflammatory cells infiltrated and fatty degeneration of hepatocytes in liver, and red pulp and white pulp were intermixed, splenic corpuscles demolished and disappeared, splenic sinusoid extended, and lymphocytes of spleen were reduced in spleen. Besides, it could also up-regulate serum levels of IL-2, IL-12, INF-γ and Ig G, reduce the level of TGF-β in serum, markedly promote mRNA expression of IL-1β, IL-4 and IL-12 in liver and spleen, and suppress mRNA expression of TGF-β. Above all, TP showed preventive effect for cyclophosphamide-induced immunosuppressed mice.Entities:
Keywords: cyclophosphamide; immunological activity; tremella polysaccharides
Mesh:
Substances:
Year: 2018 PMID: 29370108 PMCID: PMC6017040 DOI: 10.3390/molecules23020239
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Experimental process in this study.
Primer sequences used for qRT-PCR.
| Gene | Sequence (5′-3′) * | Size (bp) |
|---|---|---|
| GAAATGCCACCTTTTGACAGTG | 116 | |
| TGGATGCTCTCATCAGGACAG | ||
| GGTCTCAACCCCCAGCTAGT | 102 | |
| GCCGATGATCTCTCTCAAGTGAT | ||
| CTGGAGCACTCCCCATTCCTA | 160 | |
| GCAGACATTCCCGCCTTTG | ||
| CTTCAATACGTCAGACATTCGGG | 142 | |
| GTAACGCCAGGAATTGTTGCTA | ||
| GAGAAAATCTGGCACCACACCT | 172 | |
| GCACAGCCTGGATAGCAACGTA |
* the former was forward primer; the latter was reverse primer.
Figure 2Effect of TP on immune organ indexes, (a) thymus index and (b) spleen index. ## p < 0.01, compared to Normal. * p < 0.05; ** p < 0.01, compared to Model.
Figure 3Histopathology observation of liver (a) 200× magnification) and Spleen (b) 100× magnification.
Figure 4Effect of TP on IL-2 (a); IL-12 (b); INF-γ (c); TGF-β (d) and Ig G (e). # p < 0.05 versus Normal. ## p < 0.01 versus Normal. ** p < 0.01 versus Model.
Figure 5The levels of relative gene expression in liver. ## p < 0.01, compared to Normal. * p < 0.05, ** p < 0.01, compared to Model. (a) IL-1β expression level; (b) IL-4 expression level; (c) IL-12 expression level; (d) TGF-β expression level.
Figure 6The levels of relative gene expression in spleen. ## p < 0.01, compared to Normal. ** p < 0.01, compared to Model. (a) IL-1βexpression level; (b) IL-4 expression level; (c) IL-12 expression level; (d) TGF-β expression level.
Figure 7The mechanism of this study.